PRO DEX INC (PDEX) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$58.00

From 52W high−21.40%

Volume34049.00

Market cap$186.56M

P/E (TTM)13.7x

P/S (TTM)2.4x

Div yield—

Key dataOct 19, 2026

Open

$58.00

From 52W high

−21.40%

Volume

34049.00

Market cap

$186.56M

ValuationView details →

P/E (Fwd)

18.1x

EV/EBITDA

9.8x

P/E (TTM)

13.7x

RSI (14)

33.3

MomentumView details →

1D Return

−0.96%

YTD Return

+51.33%

SummaryUpdated Jun 1, 2026

Pro-Dex, Inc. (NASDAQ:PDEX) is a specialized medical device manufacturer founded in 1978 and headquartered in Irvine, California. The company went public in 1986 and has established itself as a niche player in the powered surgical instruments market. Pro-Dex primarily serves as an original equipment manufacturer (OEM) partner to larger medical device companies, designing and manufacturing precision surgical tools used in orthopedic, thoracic, and craniomaxillofacial procedures. The company has built its reputation on producing high-quality, autoclavable surgical instruments that meet the stringent requirements of modern operating rooms.

Ask drillr about PRO DEX INC →

ValuationView details →

P/E (Fwd)

18.1x

P/E (TTM)

13.7x

EV/EBITDA

9.8x

EV/Sales

2.5x

P/S (TTM)

2.4x

P/B (TTM)

3.9x

ProfitabilityView details →

Gross Margin

31.38%

Net Margin

17.62%

EBITDA Margin

25.73%

ROE (TTM)

28.68%

ROA (TTM)

18.34%

Asset Turnover

1.04x

GrowthView details →

Revenue YoY

+16.45%

EPS YoY

+52.90%

FCF YoY

+335.38%

Revenue CAGR 3Y

+18.94%

EPS CAGR 3Y

+28.89%

EBITDA YoY

+41.26%

MomentumView details →

1D Return

−0.96%

YTD Return

+51.33%

1Y Return

+127.11%

RSI (14)

33.3

vs 50D SMA

−11.54%

vs 200D SMA

+4.66%

Capital & dividendView details →

Debt/Equity

0.38x

Current Ratio

4.10x

Quick Ratio

2.45x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$0.87

EPS Surprise

31.02%

Beats (12Q)

9/12

Next Q EPS Est

$0.72

Avg Surprise (4Q)

38.70%

Rev Surprise

5.96%

Financials snapshotView financials →

Revenue (TTM)

77.55M

Net Income (TTM)

13.66M

Op. CF (TTM)

7.24M

Next earningsOct 29, 2026 →

Latest newsMore news →

Pro-Dex, Inc. announced its fiscal 2026 fourth quarter and full-year financial results for the period ended June 30, 2026, reporting a 17% increase in net sales to $20.4 million and a 103% increase in gross profit to $7.1 million for the quarter.46d ago

Similar companies

Utah Medical Products, Inc.UTMD Anbio Biotechnology Class A Ordinary SharesNNNN KORU Medical Systems, Inc.KRMD OraSure Technologies, Inc.OSUR Sanara MedTech Inc.SMTI Jin Medical International Ltd.ZJYL Find similar companies →

Latest newsMore news →

PRO DEX Inc, as lessee, amended its Standard Industrial/Commercial Multi-Tenant Lease with Irvine Business Properties, extending the lease term to September 30, 2030 and setting a new base rent schedule.31d ago Pro-Dex, Inc. announced its fiscal 2026 fourth quarter and full-year financial results for the period ended June 30, 2026, reporting a 17% increase in net sales to $20.4 million and a 103% increase in gross profit to $7.1 million for the quarter.46d ago